◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
DIZAL (JIANGSU) PHARMACEUTICAL — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018
+Revenue 360.0M 91.3M 0.00 10.3M 27.8M 41.0M 39.4M
Revenue Growth % 294.4% -- -100.0% -62.9% -32.3% 4.1% --
Total Revenue 360.0M 91.3M 0.00 10.3M 27.8M 41.0M 39.4M
Cost Of Revenue 9.3M 3.2M -- 9.0M 24.3M 35.8M 34.1M
+Gross Profit 350.7M 88.1M -- 1.3M 3.5M 5.2M 5.3M
Gross Margin % 97.4% 96.5% -- 12.4% 12.5% 12.7% 13.4%
Total Operating Cost 1.4B 1.3B 785.0M 692.0M 820.0M 490.0M 263.0M
Selling Expenses 445.0M 210.0M 23.0M -- -- -- --
Admin Expenses 153.0M 227.0M 105.0M 88.0M 327.0M 34.4M 20.1M
Rd Expenses 724.0M 806.0M 665.0M 588.0M 439.0M 421.0M 210.0M
Finance Expenses 23.0M 5.4M -8.2M 7.3M 27.4M -2.0M -1.7M
+Operating Income -941.0M -1.1B -736.0M -670.0M -587.0M -446.0M -174.0M
Operating Margin % -261.4% -1213.7% -- -6514.1% -2114.5% -1087.3% -441.4%
Non Operating Income 1.7M -- -- -- -- -- --
Non Operating Expenses 3,300 -- -- -- -- -- --
Investment Income -- -- -- 1.4M 2.4M 2.1M 12.1M
Fair Value Change Income 14.5M 22.5M 42.2M 973,700 292,500 446,900 943,800
Asset Disposal Income -- -8,400 17,600 -- 199.0M -- --
Other Income 41.1M 31.6M 7.2M 10.0M 3.8M 548,200 37.1M
Income Before Tax -940.0M -1.1B -736.0M -670.0M -587.0M -446.0M -174.0M
Income Tax 3,852 101,300 260,600 -- 28,400 2,653 210.66
+Net Income -940.0M -1.1B -736.0M -670.0M -587.0M -446.0M -174.0M
Net Margin % -261.1% -1213.7% -- -6514.1% -2114.5% -1087.3% -441.4%
Net Income Attributable -846.0M -1.1B -736.0M -670.0M -587.0M -446.0M -174.0M
Minority Interest -93.7M -- -- -- -- -- --
Eps Basic -2.04 -2.72 -1.82 -1.86 -1.63 -- --
Eps Diluted -2.04 -2.72 -1.82 -1.86 -1.63 -- --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018
Cash And Equivalents 250.0M 74.2M 122.0M 364.0M 509.0M 207.0M 30.3M
Trading Financial Assets 590.0M 674.0M 1.3B 1.7B 90.3M 12.4M 212.0M
Accounts Receivable 27.5M 48.0M -- 7.6M 6.9M 10.0M 21.8M
Notes And Accounts Receivable 27.5M 48.0M -- 7.6M 6.9M 10.0M 21.8M
Prepayments 61.3M 53.1M 42.3M 28.1M 18.2M 14.6M 5.3M
Inventory 44.1M 23.5M 5.1M -- -- -- --
Total Current Assets 999.0M 910.0M 1.5B 2.1B 625.0M 244.0M 270.0M
Fixed Assets -- 22.1M 12.3M 13.0M 15.0M 15.5M 6.9M
Fixed Assets Total 20.4M 22.1M 12.3M 13.0M 15.0M 15.5M 6.9M
Construction In Progress -- 13.3M 8.9M 5.0M 148,900 1.8M 1.6M
Construction In Progress Total 170.0M 13.3M 8.9M 5.0M 148,900 1.8M 1.6M
Intangible Assets 430.0M 462.0M 492.0M 475.0M 506.0M 327.0M 345.0M
Long Term Deferred Expenses 8.6M 17.0M 8.0M 4.5M 3.5M 68,300 85,800
Total Non Current Assets 720.0M 586.0M 609.0M 633.0M 557.0M 383.0M 370.0M
Total Assets 1.7B 1.5B 2.1B 2.7B 1.2B 627.0M 640.0M
Short Term Borrowings 374.0M 200.0M -- -- -- -- --
Accounts Payable 139.0M 109.0M 153.0M 132.0M 65.1M 128.0M 57.8M
Contract Liabilities 2.9M 981,800 -- -- -- -- --
Total Current Liabilities 785.0M 448.0M 248.0M 212.0M 103.0M 177.0M 96.3M
Long Term Borrowings 684.0M 138.0M -- -- -- -- --
Total Non Current Liabilities 734.0M 199.0M 74.9M 70.9M -- -- --
Total Liabilities 1.5B 648.0M 323.0M 283.0M 103.0M 177.0M 96.3M
Paid In Capital 418.0M 408.0M 407.0M 404.0M 360.0M 1.1B 743.0M
Capital Reserve 3.1B 3.0B 2.8B 2.7B 719.0M 121,300 121,300
Retained Earnings -3.4B -2.5B -1.4B -670.0M 27,400 -645.0M -199.0M
Minority Equity 6.3M -- -- -- -- -- --
Equity Attributable 194.0M 849.0M 1.8B 2.5B 1.1B 450.0M 544.0M
Total Equity 200.0M 849.0M 1.8B 2.5B 1.1B 450.0M 544.0M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018
Cash From Sales 437.0M 55.8M 7.6M 10.3M 32.7M 55.0M 21.7M
Tax Refunds Received -- 10.7M 72.6M 28.0M 24.0M -- --
Total Operating Cash Inflow 485.0M 103.0M 101.0M 50.5M 62.0M 56.3M 59.1M
Cash Paid For Goods 440.0M 623.0M 444.0M 348.0M 290.0M 282.0M 118.0M
Cash Paid To Employees 478.0M 329.0M 199.0M 143.0M 101.0M 83.0M 46.8M
Taxes Paid 20.7M 5.5M 3.9M 2.8M 2.1M 751,000 813,000
Total Operating Cash Outflow 1.1B 1.1B 704.0M 543.0M 472.0M 422.0M 196.0M
Operating Cash Flow -651.0M -968.0M -603.0M -492.0M -410.0M -366.0M -136.0M
Total Investing Cash Inflow 4.0B 4.4B 8.3B 408.0M 908.0M 675.0M 879.0M
Total Investing Cash Outflow 4.1B 3.8B 7.9B 2.0B 993.0M 487.0M 740.0M
Investing Cash Flow -38.1M 611.0M 385.0M -1.6B -85.0M 189.0M 139.0M
Cash From Borrowings 963.0M 338.0M -- 19.5M -- -- --
Dividends And Interest Paid 20.6M 3.4M -- 52,200 -- -- --
Debt Repayments 204.0M -- -- 19.5M -- -- --
Total Financing Cash Inflow 1.1B 340.0M 3.8M 2.0B 815.0M 353.0M --
Total Financing Cash Outflow 255.0M 32.1M 37.0M 60.0M -- -- --
Financing Cash Flow 867.0M 308.0M -33.3M 2.0B 815.0M 353.0M --
Net Change In Cash 176.0M -47.5M -243.0M -145.0M 302.0M 177.0M 3.5M
Ending Cash Balance 250.0M 73.9M 121.0M 364.0M 509.0M 207.0M 30.0M
Capex 138.0M 32.1M 73.8M 9.0M 212.0M 13.8M 12.2M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...